AbbVie Inc.ABBVNYSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+8.0%
5Y CAGR+11.0%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+8.0%/yr
vs +12.9%/yr prior
5Y CAGR
+11.0%/yr
Consistent
Acceleration
-4.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$51.20B+29.8%
2024$39.43B+16.3%
2023$33.90B-16.6%
2022$40.64B+4.9%
2021$38.75B+27.4%
2020$30.42B+17.8%
2019$25.83B+3.2%
2018$25.04B+18.2%
2017$21.18B+6.9%
2016$19.80B-